SCIENCE ARTICLE REPORTS DIRECT LINK BETWEEN BACTERIAL INFECTIONS AND HEART
DISEASE -- CEDARS SINAI CLINICAL TRIAL STUDYING EFFECTIVENESS OF COMMON
ANTIBIOTIC IN PREVENTING RECURRENT HEART ATTACKS
A common, inexpensive antibiotic could reduce a second heart attack in patients
who have already suffered an acute heart attack. In a clinical trial involving
1,400 patients, Cedars-Sinai Medical Center scientists, as well as
collaborators at two facilities in Israel and three in Europe, are testing the
effectiveness of the common antibiotic, Azithromycin, in preventing recurrent
heart attacks.
$5 MILLION DONATION WILL BENEFIT PATIENTS WITH BRAIN TUMORS, OTHER DEADLY BRAIN
DISORDERS (BRAIN AWARENESS WEEK IS MARCH 15-21):
Wiping out brain tumors is a top priority for Keith Black, M.D., and the other
physicians and scientists at Cedars-Sinai Medical Center's Maxine Dunitz
Neurosurgical Institute. After learning of his background and work in this area,
a life-long hospital supporter, Maxine Dunitz, donated $5 million that will
benefit patients with brain tumors formerly regarded as virtually untreatable,
as well as those with other deadly brain disorders such as aneurysms and
strokes.
WITH ALLERGY SEASON APPROACHING, NEW MEDICATIONS ARE AVAILABLE
Too many people suffer needlessly with allergies, according to Zab Mohsenifar,
M.D., director of the Division of Pulmonary/Critical Care Medicine at
Cedars-Sinai Medical Center. In many parts of the country, allergy season begins
in early to mid-March when pollens produced by a proliferation of blooming
flowers, grasses and weeds attack allergy sufferers. Although studies suggest
that the number of people with allergies is growing, there are now highly
effective medications available that do not produce unwanted side effects such
as drowsiness.
For media information and to arrange an interview, please call 1-800-396-1002.